Notably, we found that multiple myeloid subsets from the leukemic microenvironment express elevated levels of ICAM-1 and VCAM-1, suggesting that integrin binding to these adhesion molecules could activate FAK/PYK2 in T-ALL. The gene discussed is VCAM1; the disease is acute lymphoblastic leukemia.